Bronte Capital Management Pty Ltd. Cuts Stock Position in Corteva, Inc. $CTVA

Bronte Capital Management Pty Ltd. trimmed its position in Corteva, Inc. (NYSE:CTVA) by 11.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 502,790 shares of the company’s stock after selling 66,243 shares during the quarter. Corteva accounts for approximately 4.5% of Bronte Capital Management Pty Ltd.’s holdings, making the stock its 7th biggest holding. Bronte Capital Management Pty Ltd.’s holdings in Corteva were worth $42,089,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. William B. Walkup & Associates Inc. increased its position in shares of Corteva by 2.9% in the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after acquiring an additional 126 shares during the period. AdvisorNet Financial Inc grew its stake in shares of Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after purchasing an additional 135 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its holdings in Corteva by 9.1% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock valued at $112,000 after purchasing an additional 140 shares during the period. Eagle Bay Advisors LLC increased its holdings in Corteva by 4.3% during the 1st quarter. Eagle Bay Advisors LLC now owns 3,721 shares of the company’s stock valued at $312,000 after purchasing an additional 153 shares during the period. Finally, Tred Avon Family Wealth LLC raised its position in Corteva by 2.5% during the 1st quarter. Tred Avon Family Wealth LLC now owns 6,248 shares of the company’s stock valued at $523,000 after purchasing an additional 154 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on CTVA. Argus increased their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Barclays upped their target price on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Rothschild & Co Redburn raised their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Mizuho lifted their price target on shares of Corteva from $94.00 to $96.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Jefferies Financial Group boosted their price objective on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.90.

Corteva Price Performance

Shares of CTVA stock opened at $85.63 on Friday. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.95. The stock has a market cap of $57.27 billion, a price-to-earnings ratio of 50.37, a PEG ratio of 2.56 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The business’s fifty day moving average is $79.67 and its 200 day moving average is $76.80.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.